Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV)
- 23 August 2010
- Vol. 28 (37), 5960-5966
- https://doi.org/10.1016/j.vaccine.2010.07.002
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Evaluation of the safety of four porcine circovirus type 2 tissue homogenate vaccines in a pig bioassayVeterinary Record, 2009
- Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV–PCV2–SIV clinical infection model 2–3-months post vaccinationVaccine, 2008
- Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protectionJournal of General Virology, 2008
- Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in miceJournal of General Virology, 2008
- Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfectionVeterinary Microbiology, 2008
- Influence of Maternal Antibodies on Efficacy of Porcine Circovirus Type 2 (PCV2) Vaccination To Protect Pigs from Experimental Infection with PCV2Clinical and Vaccine Immunology, 2008
- Experimental Reproduction of Postweaning Multisystemic Wasting Syndrome in Pigs by Dual Infection with Mycoplasma hyopneumoniae and Porcine Circovirus Type 2Veterinary Pathology, 2004
- Experimental Inoculation of Conventional Pigs with Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus 2Journal of Virology, 2002
- Studies on epidemiology and pathogenicity of porcine circovirusArchiv für die gesamte Virusforschung, 1986
- A very small porcine virus with circular single-stranded DNANature, 1982